Shuting Yang1,2,3, Chuqing Cao1,2,3, Tuo Deng1,2,3, Zhiguang Zhou4,5,6. 1. Department of Metabolism and Endocrinology, The Second Xiangya Hospital, Central South University, Changsha, China. 2. Key Laboratory of Diabetes Immunology (Central South University), Ministry of Education, Changsha, China. 3. National Clinical Research Center for Metabolic Diseases, Changsha, China. 4. Department of Metabolism and Endocrinology, The Second Xiangya Hospital, Central South University, Changsha, China, zhouzhiguang@csu.edu.cn. 5. Key Laboratory of Diabetes Immunology (Central South University), Ministry of Education, Changsha, China, zhouzhiguang@csu.edu.cn. 6. National Clinical Research Center for Metabolic Diseases, Changsha, China, zhouzhiguang@csu.edu.cn.
Abstract
BACKGROUND: Obesity has become a major public health problem, and the prevalence of kidney diseases has increased in parallel. Among kidney diseases caused by metabolic disorders, obesity-related glomerulopathy (ORG) is secondary to obesity. SUMMARY: ORG is mainly caused by glomerular hyperfiltration, dysregulation of hormone and cytokine secretion in adipose tissues, and ectopic lipid accumulation in renal cells. ORG is pathologically characterized by glomerular hypertrophy, with or without focal and segmental glomerulosclerosis. Patients with ORG usually present with proteinuria concomitant with metabolic disorders such as dyslipidemia and hypertension. Weight loss, RAAS inhibitors, and improved insulin resistance can reduce the progression of ORG. CONCLUSION: ORG is a growing renal pathological change in obese individuals, and a comprehensive understanding of the disease is pivotal to avoid its occurrence and improve quality of life for those with obesity. Key Messages:This review comprehensively describes the characteristics of ORG in pathological changes, clinical manifestations, pathogeneses and treatments.
BACKGROUND:Obesity has become a major public health problem, and the prevalence of kidney diseases has increased in parallel. Among kidney diseases caused by metabolic disorders, obesity-related glomerulopathy (ORG) is secondary to obesity. SUMMARY: ORG is mainly caused by glomerular hyperfiltration, dysregulation of hormone and cytokine secretion in adipose tissues, and ectopic lipid accumulation in renal cells. ORG is pathologically characterized by glomerular hypertrophy, with or without focal and segmental glomerulosclerosis. Patients with ORG usually present with proteinuria concomitant with metabolic disorders such as dyslipidemia and hypertension. Weight loss, RAAS inhibitors, and improved insulin resistance can reduce the progression of ORG. CONCLUSION: ORG is a growing renal pathological change in obese individuals, and a comprehensive understanding of the disease is pivotal to avoid its occurrence and improve quality of life for those with obesity. Key Messages:This review comprehensively describes the characteristics of ORG in pathological changes, clinical manifestations, pathogeneses and treatments.
Authors: Elise Marechal; Adrien Jaugey; Georges Tarris; Michel Paindavoine; Jean Seibel; Laurent Martin; Mathilde Funes de la Vega; Thomas Crepin; Didier Ducloux; Gilbert Zanetta; Sophie Felix; Pierre Henri Bonnot; Florian Bardet; Luc Cormier; Jean-Michel Rebibou; Mathieu Legendre Journal: Clin J Am Soc Nephrol Date: 2021-12-03 Impact factor: 8.237
Authors: Hassan Reda Hassan Elsayed; Randa El-Gamal; Mohammed R Rabei; Mona G Elhadidy; Shereen Hamed; Basma H Othman; Mohamed Mahmoud Abdelraheem Elshaer; Mostafa Khaled Sedky; Ahmed Tarek Abd Elbaset Hassan; Mohammad El-Nablaway Journal: Cells Date: 2022-02-21 Impact factor: 6.600
Authors: Carlos Alberto Nogueira-de-Almeida; Luiz A Del Ciampo; Ivan S Ferraz; Ieda R L Del Ciampo; Andrea A Contini; Fábio da V Ued Journal: J Pediatr (Rio J) Date: 2020-08-04 Impact factor: 2.990